Hot pharmaceutical products for this special time
Antiviral
fapilavir
At present, clinical trials of fapilavir are carried out in Shenzhen. "On the 3rd to 4th days after treatment, the viral nucleic acid negative rate of the medication group was significantly higher than that of the control group." According to the official websites of the United States Clinical Trial Registry and the Chinese Clinical Trial Registry, there are currently three clinical trials of fapilavir for the treatment of COVID-19.
Oseltamivir

Antipyretic analgesia
Paracetamo
Antibiotic
Levofloxacin hydrochloride

to get the product you want with a lower price.
If you are looking for the above products, make a quick inquiry now!
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Get More About Antipyretic
-
What Are Clindamycin Phosphate Gel Uses
-
Do You Know Any Clindamycin Phosphate Side Effects?
-
In the 'no resistance' era, citral is promising!
-
Antibacterial, antiviral, lactoferrin have so many uses!
-
Analysis of Hot Varieties in Antiviral Raw Material Market
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
“Did They Just Buy a Money Printer for ¥288 Million?”: Yip’s Chemical’s Bold Bet on Green Tech—Is This a Genuine Transformation or Just Another Story for the Stock Market?
Recommend Reading
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
Polyester Bottle Chip Spot Price Rises on the 14th
-
Off-season effect amplifies, formic acid plunges sharply
-
Supply remains generally loose, the acrylonitrile market fluctuates within a range
-
Geopolitical Conflicts Drive a Surge in Phthalic Anhydride Prices in China
-
Notice of 2026 Chinese New Year Holiday